Recently, the APOC3 polymorphisms have been investigated the association with many diseases, such as metabolic syndrome 42, type 2 diabetes 43, coronary heart disease 44 and plasma APOC3 and lipid levels 45. Here, APOC3 is linked to coronary artery disorder.